Researchers developed a high-signal RNA imaging platform coupling CRISPR-dCas13X with binding-dependent fluorescence stabilization. The system enabled precise visualization of endogenous mRNA dynamics in living plant cells with minimal perturbation.
The 740 million parameter model runs on consumer hardware, enabling video search via voice memos and processing hours of audio with a single natively multimodal model.
Five researchers from Harvard and NIH received the 2026 Warren Alpert Foundation prize for identifying BCL11A as a key regulator of the fetal-to-adult hemoglobin switch, enabling the development of Casgevy, the first CRISPR medicine for sickle cell disease and thalassemia.
The Polars library added first-class SQL support and spill-to-disk mechanisms. Performance in TPC-H and TPC-DS1 benchmarks now surpasses DataFusion and DuckDB.
Pi 1.0 introduces Codemode, enabling LLMs to use external scripts instead of loading custom tools into the context. This approach aligns with the principle that code is all you need for effective interaction with the environment.
Researchers proposed the Neural Health Index (NHI), a single score based on five properties of brain energy organization. Across 808 participants, NHI distinguished healthy from clinical groups with sensitivity and specificity exceeding 95%.
A modified Escherichia coli Nissle 1917 strain disrupts sialic acid shielding on tumor cells, synergizing with anti-PD-L1 to suppress growth of immunologically cold tumors in mice.
Researchers developed a new aging index (CKMAI) using machine learning on 6,896 adults to better predict mortality and high-risk status in cardiovascular-kidney-metabolic syndrome.
An LLM-based agent system automatically retrieves, downloads, and reprocesses raw omics data from thousands of PubMed Central articles to enable computational reuse.
Researchers introduced Structural Myelin Integrity (SMI), a quantitative MRI metric combining Myelin Water Imaging and quantitative Magnetization Transfer sensitivities. In two rodent decompaction models and one remyelination model, SMI detected myelin layer decompaction despite largely preserved myelin membranes.
Novo Nordisk and Eli Lilly found that GLP-1 medications reduced biological age by approximately two to three years compared to placebo, though results varied by molecular clock type and organ tested.
The Phase 2/3 trial evaluates COYA 302, a combination of low-dose interleukin-2 and CTLA-4 Ig. Topline data from the 24-week phase are expected in early Q2 2027.
In the Phase 2 trial, ATH434 50 mg reduced the 11-item UMSARS Part I score by 4.64 points compared to placebo at Week 52 (p=0.032), representing roughly a 52% slowing of functional decline. Adjusting for baseline cerebrospinal fluid neurofilament light chain improved the measurement of the treatment effect.
Models achieve over 30% success in manipulation tasks without specific training, yet remain 56 points below human performance. CaP-Bench is the first comprehensive benchmark evaluating agents' ability to generate executable robot control policies.
Researchers analyzed longitudinal neuroimaging data from 353 healthy aging adults and found that deviations from sex-typical brain architecture along the sensorimotor-to-association axis overlap with psychiatric and neurological risks.
In NOTCH3 carriers, white matter hyperintensities reflect water accumulation rather than structural damage, decoupling the typical inverse relationship with brain volume. The study analyzed 44,943 participants from UK Biobank with a mean age of 64 years.
Type One Energy secured $200 million in Series B funding to advance its 400-megawatt commercial power plant project. CEO Christofer Mowry stated this capital is sufficient to complete the first plant by 2034 with less spending than competitors.
Francis Halzen received the award for developing the IceCube Neutrino Observatory and discovering high-energy neutrinos. He credits a large collaboration of researchers for the achievement.
Etched is reviewing investment bids ranging from $40 billion to $50 billion, double its current $21 billion valuation. Securing a round equal to its last funding could provide the company with a 3.5-year runway.
Researchers identified a vulnerability allowing harmful instructions to spread between AI agents and tested it on agents from Google, JP Morgan Chase, and other organizations.